Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jocelyn McLean"'
Autor:
Steven Kao, Juliet Burn, Catherine Kennedy, Jocelyn McLean, Tristan D. Yan, Brandon Lau, Brian C. McCaughan, Michael Boyer, Sanjeev Kumar
Publikováno v:
Web of Science
A small proportion of patients with malignant pleural mesothelioma (MPM) achieve pathological complete response (CR) following treatment with current practice induction chemotherapy. Our analysis of 58 patients with MPM treated with platinum-based ch
Publikováno v:
Journal of Medical Imaging and Radiation Oncology. 59:355-362
Introduction We aim to report the outcome of patients with malignant pleural mesothelioma who underwent extrapleural pneumonectomy (EPP) and adjuvant hemithoracic radiotherapy with or without chemotherapy at a single Australian institution. Method Be
Autor:
Mo Mo Tin, Christopher Cao, Catherine Kennedy, Paul G. Bannon, Jocelyn McLean, Michael Boyer, Brian C. McCaughan, Tristan D. Yan
Publikováno v:
Annals of Thoracic and Cardiovascular Surgery. 17:243-249
Background: There has been an evolving role of surgery for malignant pleural mesothelioma (MPM) over the past 25 years. The objective of this study was to investigate whether the survival results for MPM patients after surgery have improved within th
Autor:
Paul G. Bannon, Michael Boyer, Catherine Kennedy, Brian C. McCaughan, Tristan D. Yan, Mo Mo Tin, Jocelyn McLean, Daniel Wong
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 138(3):619-624
Objective This study aimed to evaluate the perioperative and long-term outcomes associated with extrapleural pneumonectomy for patients with malignant pleural mesothelioma. Methods From October 1994 to April 2008, 70 patients were selected for extrap
Autor:
Christine Pollicino, Michael Boyer, Brian C. McCaughan, Patricia Kenny, Rosalie Viney, Jocelyn McLean, Michael J. Fulham, Madeleine King
Publikováno v:
Journal of Clinical Oncology. 26:233-241
PurposeAlthough surgery for early-stage non–small-cell lung cancer (NSCLC) is known to have a substantial impact on health-related quality of life (HRQOL), there are few published studies about HRQOL in the longer term. This article examines HRQOL
Autor:
Madeleine King, Christine Pollicino, Jocelyn McLean, Michael Boyer, Michael J. Fulham, Patricia Kenny, Rosalie Viney, Brian C. McCaughan
Publikováno v:
Journal of Clinical Oncology. 22:2357-2362
Purpose Positron emission tomography (PET) is a costly new technology with potential to improve preoperative evaluation for patients with non–small-cell lung cancer (NSCLC). There is increasing pressure for PET to be included in standard diagnostic
Publikováno v:
Journal of medical imaging and radiation oncology. 59(3)
We aim to report the outcome of patients with malignant pleural mesothelioma who underwent extrapleural pneumonectomy (EPP) and adjuvant hemithoracic radiotherapy with or without chemotherapy at a single Australian institution.Between July 2004 and M
Autor:
Nico, van Zandwijk, Christopher, Clarke, Douglas, Henderson, A William, Musk, Kwun, Fong, Anna, Nowak, Robert, Loneragan, Brian, McCaughan, Michael, Boyer, Malcolm, Feigen, David, Currow, Penelope, Schofield, Beth Ivimey, Nick Pavlakis, Jocelyn, McLean, Henry, Marshall, Steven, Leong, Victoria, Keena, Andrew, Penman
Publikováno v:
Journal of thoracic disease. 5(6)
Autor:
Tristan D, Yan, Momo, Tin, Michael, Boyer, Jocelyn, McLean, Paul, G Bannon, Brian C, McCaughan
Publikováno v:
Journal of thoracic disease. 1(1)
Extrapleural pneumonectomy (EPP) has been used as a treatment option for selected patients with malignant pleural mesothelioma (MPM). The primary end-point of this study was disease-free survival (DFS). Prognostic indicators for local and overall DFS
Autor:
Michael Boyer, Mo Mo Tin, Tristan D. Yan, Brian C. McCaughan, Catherine Kennedy, Paul G. Bannon, Junyang Sim, Jocelyn McLean
Publikováno v:
The Annals of thoracic surgery. 87(5)
The primary aim of this study was to evaluate prognostic features of long-term survivors with pleural mesothelioma.Overall survival outcome was analyzed in 456 patients with malignant pleural mesothelioma who underwent extrapleural pneumonectomy (EPP